|
1
|
Mont MA, Jones LC and Hungerford DS:
Nontraumatic osteonecrosis of the femoral head: Ten years later. J
Bone Joint Surg Am. 88:1117–1132. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mont MA, Cherian JJ, Sierra RJ, Jones LC
and Lieberman JR: Nontraumatic osteonecrosis of the femoral head:
Where do we stand today? A ten-year update. J Bone Joint Surg Am.
97:1604–1627. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao DW, Yu M, Hu K, Wang W, Yang L, Wang
BJ, Gao XH, Guo YM, Xu YQ, Wei YS, et al: Prevalence of
nontraumatic osteonecrosis of the femoral head and its associated
risk factors in the Chinese population: Results from a nationally
representative survey. Chin Med J (Engl). 128:2843–2850. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tan G, Kang PD and Pei FX: Glucocorticoids
affect the metabolism of bone marrow stromal cells and lead to
osteonecrosis of the femoral head: A review. Chin Med J (Engl).
125:134–139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zalavras CG and Lieberman JR:
Osteonecrosis of the femoral head: Evaluation and treatment. J Am
Acad Orthop Surg. 22:455–464. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pouya F and Kerachian MA: Avascular
necrosis of the femoral head: Are any genes involved? Arch Bone Jt
Surg. 3:149–155. 2015.PubMed/NCBI
|
|
7
|
Gómez-Mont Landerreche JG, Gil-Orbezo F,
Morales-Dominguez H, Navarrete-Álvarez M, Trueba-Davalillo C and
Capuano-Tripp P: Nontraumatic causes of bilateral avascular
necrosis of the femoral head: Link between hepatitis C and
pegylated interferon. Acta Ortop Mex Mex and pegylated interferon.
Acta Ortop Mex. 29:172–175. 2015.(In Spanish). PubMed/NCBI
|
|
8
|
Farrier AJ, Franco LC Sanchez, Shoaib A,
Gulati V, Johnson N, Uzoigwe CE and Choudhury MZ: New
anti-resorptives and antibody mediated anti-resorptive therapy.
Bone Joint J. 98-B:1–165. 2016. View Article : Google Scholar :
|
|
9
|
Mont MA, Jones LC, Einhorn TA, Hungerford
DS and Reddi AH: Osteonecrosis of the femoral head. Potential
treatment with growth and differentiation factors. Clin Orthop
Relat Res. (355 Suppl): S314–S335. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Letterio JJ and Roberts AB: Regulation of
immune responses by TGF-beta. Annu Rev Immunol. 16:137–161. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Massagué J: TGF-beta signal transduction.
Annu Rev Biochem. 67:753–791. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schultze-Mosgau S, Lehner B, Rödel F,
Wehrhan F, Amann K, Kopp J, Thorwarth M, Nkenke E and Grabenbauer
G: Expression of bone morphogenic protein 2/4, transforming growth
factor-beta1, and bone matrix protein expression in healing area
between vascular tibia grafts and irradiated bone-experimental
model of osteonecrosis. Int J Radiat Oncol Biol Phys. 61:1189–1196.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mouzas OD, Zibis AH, Bonotis KS,
Katsimagklis CD, Hadjigeorgiou GM, Papaliaga MN, Dimitroulias AP
and Malizos KN: Psychological distress, personality traits and
functional disability in patients with osteonecrosis of the femoral
head. J Clin Med Res. 6:336–344. 2014.PubMed/NCBI
|
|
14
|
Ficat RP: Idiopathic bone necrosis of the
femoral head. Early diagnosis and treatment. J Bone Joint Surg Br.
67:3–9. 1985.PubMed/NCBI
|
|
15
|
Zhang H, Xiao F, Liu Y, Zhao D, Shan Y and
Jiang Y: A higher frequency of peripheral blood activated B cells
in patients with non-traumatic osteonecrosis of the femoral head.
Int Immunopharmacol. 20:95–100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zheng L, Wang W, Ni J, Li Z and Xiao T:
The association of eNOS gene polymorphism with avascular necrosis
of femoral head. PLoS One. 9:e875832014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hong YC, Luo RB, Lin T, Zhong HM and Shi
JB: Efficacy of alendronate for preventing collapse of femoral head
in adult patients with nontraumatic osteonecrosis. Biomed Res Int.
2014:7165382014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sakaguchi M, Tanaka T, Fukushima W, Kubo T
and Hirota Y; Idiopathic ONF Multicenter Case-Control Study Group,
: Impact of oral corticosteroid use for idiopathic osteonecrosis of
the femoral head: A nationwide multicenter case-control study in
Japan. J Orthop Sci. 15:185–191. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lykissas MG, Gelalis ID, Kostas-Agnantis
IP, Vozonelos G and Korompilias AV: The role of hypercoagulability
in the development of osteonecrosis of the femoral head. Orthop Rev
(Pavia). 4:e172012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kapoor M, Martel-Pelletier J, Lajeunesse
D, Pelletier JP and Fahmi H: Role of proinflammatory cytokines in
the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 7:33–42.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hong JM, Kim TH, Kim HJ, Park EK, Yang EK
and Kim SY: Genetic association of angiogenesis- and
hypoxia-related gene polymorphisms with osteonecrosis of the
femoral head. Exp Mol Med. 42:376–385. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Seamon J, Keller T, Saleh J and Cui Q: The
pathogenesis of nontraumatic osteonecrosis. Arthritis.
2012:6017632012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Plaas A, Velasco J, Gorski DJ, Li J, Cole
A, Christopherson K and Sandy JD: The relationship between
fibrogenic TGFβ1 signaling in the joint and cartilage degradation
in post-injury osteoarthritis. Osteoarthritis Cartilage.
19:1081–1090. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Finnson KW, McLean S, Di Guglielmo GM and
Philip A: Dynamics of transforming growth factor beta signaling in
wound healing and scarring. Adv Wound Care (New Rochelle).
2:195–214. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Penn JW, Grobbelaar AO and Rolfe KJ: The
role of the TGF-β family in wound healing, burns and scarring: A
review. Int J Burns Trauma. 2:18–28. 2012.PubMed/NCBI
|
|
26
|
Bastian O, Pillay J, Alblas J, Leenen L,
Koenderman L and Blokhuis T: Systemic inflammation and fracture
healing. J Leukoc Biol. 89:669–673. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang H, Gao F, Li X, Wang J, Liu H and
Zheng Z: TGF-β1 antagonizes TNF-α induced up-regulation of matrix
metalloproteinase 3 in nucleus pulposus cells: Role of the ERK1/2
pathway. Connect Tissue Res. 56:461–468. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rivas M Noval, Weatherly K, Hazzan M,
Vokaer B, Dremier S, Gaudray F, Goldman M, Salmon I and Braun MY:
Reviving function in CD4+ T cells adapted to persistent systemic
antigen. J Immunol. 183:4284–4291. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kumarasinghe DD, Sullivan T, Kuliwaba JS,
Fazzalari NL and Atkins GJ: Evidence for the dysregulated
expression of TWIST1, TGFβ1 and SMAD3 in differentiating
osteoblasts from primary hip osteoarthritis patients.
Osteoarthritis Cartilage. 20:1357–1366. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Feng W, Ying WZ, Aaron KJ and Sanders PW:
Transforming growth factor-β mediates endothelial dysfunction in
rats during high salt intake. Am J Physiol Renal Physiol.
309:F1018–F1025. 2015. View Article : Google Scholar : PubMed/NCBI
|
